Rankings
▼
Calendar
IMA Q3 2025 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena
IMA
ImageneBio Inc
$67M
Q3 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$27M
Net Income
-$25M
EPS (Diluted)
$-3.01
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$27M
Free Cash Flow
-$27M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$161M
Total Liabilities
$21M
Stockholders' Equity
$140M
Cash & Equivalents
$103M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$7M
+100.0%
Operating Income
-$27M
-$12M
-114.3%
Net Income
-$25M
-$10M
-142.1%
← Q2 2025
All Quarters